BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 21409742)

  • 21. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer.
    Briganti A; Chun FK; Salonia A; Suardi N; Gallina A; Da Pozzo LF; Roscigno M; Zanni G; Valiquette L; Rigatti P; Montorsi F; Karakiewicz PI
    Eur Urol; 2006 Nov; 50(5):1006-13. PubMed ID: 16959399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for pelvic lymphoceles post-radical prostatectomy.
    Khoder WY; Trottmann M; Buchner A; Stuber A; Hoffmann S; Stief CG; Becker AJ
    Int J Urol; 2011 Sep; 18(9):638-43. PubMed ID: 21689165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability of preoperative diagnostics and location of lymph node metastases in presumed unilateral prostate cancer.
    Weckermann D; Holl G; Dorn R; Wagner T; Harzmann R
    BJU Int; 2007 May; 99(5):1036-40. PubMed ID: 17437437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer.
    Briganti A; Chun FK; Salonia A; Gallina A; Farina E; Da Pozzo LF; Rigatti P; Montorsi F; Karakiewicz PI
    BJU Int; 2006 Oct; 98(4):788-93. PubMed ID: 16796698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pelvic lymph node dissection in prostate cancer.
    Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
    Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
    Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
    Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extending the indications and anatomical limits of pelvic lymph node dissection for prostate cancer: improved staging or increased morbidity?
    Touijer K; Fuenzalida RP; Rabbani F; Paparel P; Nogueira L; Cronin AM; Fine SW; Guillonneau B
    BJU Int; 2011 Aug; 108(3):372-7. PubMed ID: 21199284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [First results of PET / CT-guided secondary lymph node surgery on patients with a PSA relapse after radical prostatectomy].
    Winter A; Uphoff J; Henke RP; Wawroschek F
    Aktuelle Urol; 2009 Sep; 40(5):294-9. PubMed ID: 19533582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Robot-assisted extended pelvic lymph node dissection (PLND) at the time of radical prostatectomy (RP): a video-based illustration of technique, results, and unmet patient selection needs.
    Davis JW; Shah JB; Achim M
    BJU Int; 2011 Sep; 108(6 Pt 2):993-8. PubMed ID: 21917102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
    Bhatta-Dhar N; Reuther AM; Zippe C; Klein EA
    Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy.
    Schumacher MC; Burkhard FC; Thalmann GN; Fleischmann A; Studer UE
    Eur Urol; 2008 Aug; 54(2):344-52. PubMed ID: 18511183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nodal counts during pelvic lymph node dissection for prostate cancer: an objective indicator of quality under the influence of very subjective factors.
    Mazzola C; Savage C; Ahallal Y; Reuter VE; Eastham JA; Scardino PT; Guillonneau B; Touijer KA
    BJU Int; 2012 May; 109(9):1323-8. PubMed ID: 21992661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Open pelvic lymph node dissection for prostate cancer: a reassessment.
    Campbell SC; Klein EA; Levin HS; Piedmonte MR
    Urology; 1995 Sep; 46(3):352-5. PubMed ID: 7544933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of the extent of lymph-node dissection on biochemical relapse after radical prostatectomy in node-negative patients.
    Schiavina R; Bertaccini A; Franceschelli A; Manferrari F; Vagnoni V; Borghesi M; Morselli-Labate AM; Martorana G
    Anticancer Res; 2010 Jun; 30(6):2297-302. PubMed ID: 20651383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma.
    Haese A; Epstein JI; Huland H; Partin AW
    Cancer; 2002 Sep; 95(5):1016-21. PubMed ID: 12209685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
    Briganti A; Karakiewicz PI; Chun FK; Suardi N; Gallina A; Abdollah F; Freschi M; Doglioni C; Rigatti P; Montorsi F
    Int J Urol; 2009 Aug; 16(8):676-81. PubMed ID: 19602006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer.
    Wyler SF; Sulser T; Seifert HH; Ruszat R; Forster TH; Gasser TC; Bachmann A
    Urology; 2006 Oct; 68(4):883-7. PubMed ID: 17070376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.